From Indiana, USA:
My daughter is 18 and has Type 1 diabetes. She has been a diabetic for 5 years. She has been noncompliant with this disease. She has had 7 DKA's in the past 5 years. We have had her on Prozac and Ritalin [medications to help improve mood] and even chromium. Nothing has helped. We recently switched her doctor to an adult endocrinologist. He is very unhappy with her A1c which is 12. He wants to put her Avandia to see if her body will react to the insulin better. He said she wasn't in the honeymoon any more. The Avandia drug is for Type 2 diabetics -- will this work for my daughter? I am scared she is just willing to give up on life.
Avandia [rosiglitazone, a pill for Type 2 diabetes] increases insulin sensitivity in type 2 diabetes. There are no formal indications for Avandia in children or adults with type 1 diabetes. I would suggest talking to your new doctor about why he wants to use Avandia for your daughter.
Additional comments from Dr. Quick:It's unclear from your letter if your daughter has had the opportunity to interact with a counselor who's trained in dealing with teens with chronic disease. If yes, encourage her to continue. If not, insist she see one, preferably one who's affiliated with a diabetes team.
This doesn't sound like a situation where adding pills for diabetes would be likely to help improve her mood.
Original posting 7 Oct 1999
Posted to Medications: Pills for Diabetes
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:09:06
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.